Improved Effects of Viral Gene Delivery of Human Upa plus Biliodigestive Anastomosis Induce Recovery from Experimental Biliary Cirrhosis

[1]  D. Brenner,et al.  Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. , 2003, Gastroenterology.

[2]  S. Krane,et al.  Mutation in collagen‐I that confers resistance to the action of collagenase results in failure of recovery from CCl4‐induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Molecular therapy , 2002, Journal of the Neurological Sciences.

[4]  Z. Zhong,et al.  Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat , 2002, Gene Therapy.

[5]  J. Armendáriz-Borunda,et al.  Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion , 2002, Gene Therapy.

[6]  R. Sokol,et al.  Survival after first esophageal variceal hemorrhage in patients with biliary atresia. , 2001, The Journal of pediatrics.

[7]  T. Thompson,et al.  Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  B. Miles,et al.  In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  J. Armendáriz-Borunda,et al.  Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity. , 2000, Journal of hepatology.

[10]  J. Armendáriz-Borunda,et al.  Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  J. Pickleman,et al.  Portoenterostomy: an old treatment for a new disease. , 2000, Archives of surgery.

[12]  O. Chazouilleres,et al.  Chronic cholestatic diseases. , 2000, Journal of hepatology.

[13]  W. Harmsen,et al.  Long-term results of biliary reconstruction after laparoscopic bile duct injuries. , 1999, Archives of surgery.

[14]  K. Lindor,et al.  Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis , 1999, Hepatology.

[15]  D. Owczarek,et al.  [The influence of ursodeoxycholic acid on some biochemical, immunologic and histopathologic parameters in patients with primary biliary cirrhosis]. , 1999, Przeglad lekarski.

[16]  P. Shabram,et al.  Sensitivity and reproducibility in adenoviral infectious titer determination , 1997, Nature Medicine.

[17]  M. Kaplan,et al.  Sustained Biochemical and Histologic Remission of Primary Biliary Cirrhosis in Response to Medical Treatment , 1997, Annals of Internal Medicine.

[18]  R. Sokol,et al.  Long-term results with the Kasai operation for biliary atresia. , 1996, Archives of surgery.

[19]  A. Gown,et al.  A modified urokinase plasminogen activator induces liver regeneration without bleeding. , 1995, Human gene therapy.

[20]  R. Rossi,et al.  Biliary reconstruction. , 1994, The Surgical clinics of North America.

[21]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[22]  A. Zimmermann,et al.  Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. , 1992, Gastroenterology.

[23]  B. Balkau,et al.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.

[24]  P. Whitington,et al.  Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. , 1991, The Journal of pediatrics.

[25]  J. Bircher,et al.  Ursodeoxycholic acid–induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis , 1990, Hepatology.

[26]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[27]  T. Starzl,et al.  LIVER TRANSPLANTATION (First of Two Parts) , 1989 .

[28]  D. V. van Thiel,et al.  Liver transplantation (1). , 1989, The New England journal of medicine.

[29]  M. Rojkind,et al.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  F. Schaffner,et al.  Serum bilirubin: a prognostic factor in primary biliary cirrhosis. , 1979, Gut.

[31]  T. Starzl,et al.  Liver transplantation. , 1989, The Johns Hopkins medical journal.

[32]  M. Kasai.  Treatment of biliary atresia with special reference to hepatic porto-enterostomy and its modifications. , 1974, Progress in pediatric surgery.